Home » Topics » BioWorld Science

BioWorld Science
RSS

Actavalon patents AhR agonists for cancer

May 29, 2018

New IDO-1 inhibitor PX-D26116 has improved metabolic stability compared to epacadostat

May 29, 2018

EMA accepts European filing for edaravone for ALS

May 29, 2018

Researchers present new antiviral compounds

May 29, 2018

Mouse model of VIPR2 gene copy number variation gives insight into neuropsychiatric disorders

May 29, 2018

Novel experimental model of ZIKV infection with pregnant common marmoset presented

May 29, 2018

Researchers present novel bifunctional mu-receptor agonist and NPFF receptor antagonist, KGFF-09

May 29, 2018

Prothena reorganizing resources to advance neuroscience pipeline

May 29, 2018

Polysialic acid levels tied to prostate cancer aggressiveness

May 28, 2018

Mepolizumab approved for EGPA in Japan

May 28, 2018

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...